Yonghe Medical Group Co., Ltd. reported that its authorised and issued share capital remained unchanged throughout March 2026.

The authorised share capital stayed at 20 billion ordinary shares with a par value of USD 0.0000025 each, equivalent to USD 50,000 in total.

Issued share capital (excluding treasury shares) closed the month at 525.22 million shares, while treasury shares held by the company totaled 0.25 million. Consequently, total issued shares stood at 525.47 million. No new shares were issued, cancelled, or repurchased during the period.

Management confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 % public-float requirement.

The filing shows no movements in share options, warrants, convertibles or other equity-linked instruments, and no Hong Kong Depositary Receipts are outstanding. Director Zhang Yu submitted the return on 2 April 2026.